New EU members get packaging directive extension:
This article was originally published in Clinica
Executive Summary
The European Commission has issued Directive 2005/20/EC giving the new EU member states an extension to the deadline by which they must comply with Directive 94/62/EC on packaging and packaging waste. Member states that joined the EU last May have until September 9 2006 to bring into force the laws, regulations and administrative provisions necessary to comply with the Directive. They are then entitled to postpone the attainment of the targets, as set out in paragraphs 1b, d and e of the main Directive until a date of their own choosing, but which must be not later than: December 31 2012 for the Czech Republic, Estonia, Cyprus, Lithuania, Hungary, Slovenia and Slovakia; December 31 2013 for Malta; December 31 2014 for Poland; and December 31 2015 for Latvia. The new Directive was published in the Official Journal of the European Union on March 16 2005.
You may also be interested in...
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.